Pharmacists to Descend on Washington March 24, 2017 By Christine Blank DIR fees and health-care reform will lead pharmacists’ legislative concerns. DIRs: PBMs Pay Less Each Year While Prices Go Up March 16, 2017 By David Stanley RPh PBMs have a business model where they pay less even while prices go up. Diabetic patients challenge insulin makers February 06, 2017 By Christine Blank In the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers. Value-based care takes over J.P. Morgan Healthcare Conference 2017 January 23, 2017 By Marc O'Connor Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference. Battling DIR Fees October 06, 2016 By Christine Blank The profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions. Every pharmacist has them — and so does every teacher August 10, 2016 By David Stanley RPh What do pharmacists and teachers — and an awful lot of other people — have in common? Is Express Scripts ‘slamming’ pharmacy customers? August 08, 2016 By Mark Lowery Editor Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts. Explore three pathways to fast-growing pharmacy niche July 10, 2016 By Jill Sederstrom There are more ways than one to run a specialty pharmacy — and success can be found with any of them. Survey finds stakeholders lack understanding of biosimilars June 27, 2016 By Tracey Walker It is important to look at how the introduction of biosimilars in the United States may affect your business and your stakeholders and plan for those changes accordingly, according to a new report.